2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
7
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10180
Neoplasms
7807
Carcinoma, Non-Small-Cell Lung
5756
Prostatic Neoplasms
5024
Colorectal Neoplasms
4603
Lung Neoplasms
3723
Leukemia, Myeloid, Acute
3102
Neoplasm Metastasis
3082
Multiple Myeloma
3081
Pancreatic Neoplasms
2843
Melanoma
2651
Ovarian Neoplasms
2573
Lymphoma
2570
Carcinoma, Hepatocellular
2479
Stomach Neoplasms
2329
Recurrence
2229
Head and Neck Neoplasms
2102
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2086
Lymphoma, Non-Hodgkin
2057
Leukemia
2013
Brain Neoplasms
1902
Glioblastoma
1795
Colonic Neoplasms
1790
Leukemia, Lymphocytic, Chronic, B-Cell
1771
Rectal Neoplasms
1719
Uterine Cervical Neoplasms
1693
Squamous Cell Carcinoma of Head and Neck
1654
Lymphoma, Follicular
1651
Lymphoma, Large B-Cell, Diffuse
1597
Carcinoma, Renal Cell
1577
Interventions
enoxaparin sodium
1
Injections
1
Dalteparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Thrombophilia
×
Clear all
NCT06153394
2024-04-23
PRIORITY
Western University, Canada
Phase 3
Not yet recruiting
50 enrolled